相关实验视频

Updated: Jan 8, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

在卵巢癌中,CCR2改善了瘤导向的CAR-T细胞贩运

Raj Kumar¹, Irva E Veillard¹, Mengyao Xu¹

¹Massachusetts General Hospital Cancer Center, Boston, MA, United States.

Frontiers in pharmacology

|December 22, 2025

概括

研究人员增强了化学抗原受体 (CAR) -T细胞以准卵巢癌,通过将它们武装为化学因子CCL2.2的受体. 这在患有腹腔瘤的小鼠中改善了CAR-T细胞贩运和存活率.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
癌症生物学癌症生物学

背景情况:

固体瘤,特别是患有腹膜转移的卵巢癌,由于T细胞透不良,对化学抗原受体 (CAR) -T细胞疗法构成挑战.
系统性输送CAR-T细胞在达到腹腔内的瘤部位时面临着重大贩运障碍.

研究的目的:

为了确定可以引导CAR-T细胞到卵巢瘤的化学基因.
设计具有增强定位能力的CAR-T细胞,以提高卵巢癌的疗效.

主要方法:

免疫组织化学被用来评估卵巢癌患者样本中的化学激素表达.
在卵巢癌细胞系和患者血清中验证了CCL2和CCL4表达.
针对Muc16/CA-125的CAR-T细胞被设计成具有CCL2和CCL4.4的受体.

主要成果:

在初级和转移性卵巢瘤中,CCL2被确定为高度表达的化学激素.
改造的CAR-T细胞在体外和体内都表现出增强的瘤导向贩运.
静脉注射CCL2-武装的CAR-T细胞显著改善了患有腹膜卵巢瘤的小鼠的生存率.

结论:

CCL2是卵巢癌中的一个关键化学因子,表明其作为指导目标的潜力.
武装CAR-T细胞以准CCL2可增强它们的腹膜贩运和抗瘤功效.
这一战略为克服卵巢癌CAR-T细胞治疗的贩运挑战提供了一个有希望的方法.

关键词:

在CAR-T细胞中.16 亿元人民币16 亿元人民币有武装的CAR-T细胞.化学物质 (chemokines) 是一种化学物质.仿真抗原受体T细胞的T细胞.卵巢癌是发生在卵巢的癌症.

更多相关视频

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...